Roche's multiple sclerosis drug fenebrutinib meets goal in late-stage trial - Reuters

Reuters | Feb. 7, 2026, 3:44 p.m. | Original
Roche's multiple sclerosis drug fenebrutinib meets goal in late-stage trial Reuters
Hims to stop offering GLP-1 pill after FDA warned of crackdown - Reuters South Africa keen to utilise new ECB repo lines, central bank governor says - Reuters